RN1101
/ AlloRunning Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 10, 2025
A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
(clinicaltrials.gov)
- P1 | N=21 | Recruiting | Sponsor: YANRU WANG | Not yet recruiting ➔ Recruiting
Enrollment open • B Cell Lymphoma • Hematological Malignancies • Lymphoma • Multiple Myeloma • Non-Hodgkin’s Lymphoma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1